Catalent, Inc.·4

Jul 5, 9:46 PM ET

Arnold Jonathan 4

4 · Catalent, Inc. · Filed Jul 5, 2022

Insider Transaction Report

Form 4
Period: 2022-07-01
Arnold Jonathan
President, Oral Drug Delivery
Transactions
  • Award

    Common Stock

    2022-07-01$107.02/sh+2,804$300,08448,792 total
Footnotes (2)
  • [F1]Restricted stock units (RSUs) received under the Issuer's omnibus incentive plan in connection with reporting person's promotion to a new executive position. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award.
  • [F2]Includes restricted stock units.

Documents

1 file
  • 4
    wf-form4_165707194203046.xmlPrimary

    FORM 4